NCT00170963View on ClinicalTrials.gov

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone

PHASE3CompletedINTERVENTIONAL
Enrollment

1,018

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Hypertension
Interventions
DRUG

valsartan/amlodipine

Trial Locations (2)

Unknown

Investigative Centers

Novartis Pharmaceuticals, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY